Anthony Klugman

604 total citations
8 papers, 442 citations indexed

About

Anthony Klugman is a scholar working on Pharmacology, Biological Psychiatry and Molecular Biology. According to data from OpenAlex, Anthony Klugman has authored 8 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pharmacology, 3 papers in Biological Psychiatry and 2 papers in Molecular Biology. Recurrent topics in Anthony Klugman's work include Tryptophan and brain disorders (3 papers), Pharmacological Effects and Toxicity Studies (2 papers) and Alzheimer's disease research and treatments (2 papers). Anthony Klugman is often cited by papers focused on Tryptophan and brain disorders (3 papers), Pharmacological Effects and Toxicity Studies (2 papers) and Alzheimer's disease research and treatments (2 papers). Anthony Klugman collaborates with scholars based in United Kingdom and India. Anthony Klugman's co-authors include Torsten Baldeweg, Steven R. Hirsch, John Gruzelier, Naji Tabet, Mokhtar Isaac, Iltaf Shah, Andrea Petróczi, Declan P. Naughton, John Gruzelier and Justin Sauer and has published in prestigious journals such as Cochrane Database of Systematic Reviews, Schizophrenia Research and Journal of Alzheimer s Disease.

In The Last Decade

Anthony Klugman

8 papers receiving 434 citations

Peers

Anthony Klugman

CN

ECP

SP

PMH

SP

Richard T. Ward United States

Sean O’Connor United States

Shabah M. Shadli New Zealand

Yann Hodé France

B. S. Kopell United States

Sandra Pusil Spain

Shiori Honda Japan

Márk Molnár Hungary

Anna Neukirch Germany

Maria Sekutowicz Germany

Richard T. Ward United States

Anthony Klugman

115 ×0.3

CN

56 ×0.7

ECP

8 ×0.1

SP

45 ×0.8

PMH

25 ×0.7

SP

Citations per year, relative to Anthony Klugman Anthony Klugman (= 1×) peers Richard T. Ward

Countries citing papers authored by Anthony Klugman

Since Specialization

Citations

This map shows the geographic impact of Anthony Klugman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony Klugman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony Klugman more than expected).

Fields of papers citing papers by Anthony Klugman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony Klugman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony Klugman. The network helps show where Anthony Klugman may publish in the future.

Co-authorship network of co-authors of Anthony Klugman

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony Klugman. A scholar is included among the top collaborators of Anthony Klugman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony Klugman. Anthony Klugman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Gard, Paul R., et al.. (2013). Blood pro‐inflammatory cytokines in Alzheimer's disease in relation to the use of acetylcholinesterase inhibitors. International Journal of Geriatric Psychiatry. 28(12). 1312–1317. 19 indexed citations

2.

Shah, Iltaf, Andrea Petróczi, Naji Tabet, et al.. (2012). Low 25OH Vitamin D2 Levels Found in Untreated Alzheimer’s Patients, Compared to Acetylcholinesterase-Inhibitor Treated and Controls. Current Alzheimer Research. 9(9). 1069–1076. 13 indexed citations

3.

Klugman, Anthony, Declan P. Naughton, Mokhtar Isaac, et al.. (2012). Antioxidant Enzymatic Activities in Alzheimer's Disease: The Relationship to Acetylcholinesterase Inhibitors. Journal of Alzheimer s Disease. 30(3). 467–474. 29 indexed citations

4.

Shah, Iltaf, et al.. (2011). Acetylcholinesterase inhibitors normalise circulating vitamin D2 levels in Alzheimer's disease: an observational study. Research Repository (Kingston University London). 1 indexed citations

5.

Klugman, Anthony, Justin Sauer, Naji Tabet, & Robert Howard. (2004). Alpha lipoic acid for dementia. Cochrane Database of Systematic Reviews. 2010(1). CD004244–CD004244. 15 indexed citations

6.

Baldeweg, Torsten, Anthony Klugman, John Gruzelier, & Steven R. Hirsch. (2003). Mismatch negativity potentials and cognitive impairment in schizophrenia. Schizophrenia Research. 69(2-3). 203–217. 250 indexed citations

7.

Klugman, Anthony & John Gruzelier. (2003). Chronic cognitive impairment in users of 'ecstasy' and cannabis.. PubMed. 2(3). 184–90. 12 indexed citations

8.

Baldeweg, Torsten, Anthony Klugman, John Gruzelier, & Steven R. Hirsch. (2002). Impairment in frontal but not temporal components of mismatch negativity in schizophrenia. International Journal of Psychophysiology. 43(2). 111–122. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact